Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer
Clinical trial NCT06192680 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06192680
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-11-30
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.